Enduring Clinical Remission in Refractory Celiac Disease Type II With Tofacitinib: An Open-Label Clinical Study

被引：5
|
作者：
Dieckman, Tessa [1 ,2 ]
Schumann, Michael [3 ]
Beaumont, Hanneke [2 ]
Bontkes, Hetty j. [4 ]
Koning, Frits [1 ]
Bouma, Gerd [2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Immunol, Leiden, Netherlands
[2] Vrije Univ Amsterdam Amsterdam Gastroenterol Endoc, Dept Gastroenterol & Hepatol, Amsterdam UMC, Amsterdam, Netherlands
[3] Charite Univ Med Berlin, Div Gastroenterol Infect Dis & Rheumatol, Campus Benjamin Franklin, Berlin, Germany
[4] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam UMC locat, Lab Specialized Diagnost & Res,Dept Lab Med,Med Im, Amsterdam, Netherlands
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 22卷 / 11期
关键词：
BUDESONIDE;
D O I：
10.1016/j.cgh.2024.05.022
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2334 / 2336
页数：3
相关论文
共 50 条
  • [41] Maintenance of Remission with Tofacitinib in Patients With Ulcerative Colitis: Subpopulation Analysis from an Open-Label, Long-Term Extension Study
    Jean-Frederic, Colombel
    Walter, Reinisch
    Mark, Osterman T.
    Andrew, Thorpe J.
    Chudy, Nduaka, I
    Zhang Haiying
    Nervin, Lawendy
    Gary, Friedman S.
    Su Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S4 - S4
  • [42] Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study
    Syal, Gaurav
    Mishkin, Daniel S.
    Banty, Andrea
    Lee, Susie
    Fontelera, Norma
    Hampton, Melissa
    Ziring, David
    Fleshner, Phillip R.
    Melmed, Gil Y.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (10) : 1907 - 1910
  • [43] Phase II Optimization, Open-Label Clinical Trial of Zalypsis® (PM00104) in Relapsed/Refractory Multiple Myeloma Patients
    Ocio, Enrique M.
    De La Rubia, Javier
    Oriol-Rocafiguera, Albert
    Blade, Joan
    Rodriguez, Jose
    Coronado, Cinthya
    Martin Sanchez, Jesus
    Isabel Teruel, Ana
    Hernandez-Maraver, Dolores
    Prosper, Felipe
    San-Miguel, Jesus. F.
    BLOOD, 2012, 120 (21)
  • [44] Alemtuzumab treatment of refractory celiac disease type II
    Lundin, Knut E.
    Farstad, Inger Nina
    Raki, Melinda
    Benestad, Yngve
    Hoie, Ole
    Tjonnfjord, Geir
    GASTROENTEROLOGY, 2006, 130 (04) : A666 - A666
  • [45] Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study)
    Verheye, Stefan
    Agostoni, Pierfrancesco
    Giannini, Francesco
    Hill, Jonathan M.
    Jensen, Christoph
    Lindsay, Steven
    Stella, Pieter R.
    Redwood, Simon
    Banai, Shmuel
    Konigstein, Maayan
    EUROINTERVENTION, 2021, 17 (07) : 561 - +
  • [46] Clinical profile of gilteritinib in Japanese patients with relapsed/refractory acute myeloid leukemia: An open-label phase 1 study
    Usuki, Kensuke
    Sakura, Toru
    Kobayashi, Yukio
    Miyamoto, Toshihiro
    Iida, Hiroatsu
    Morita, Satoshi
    Bahceci, Erkut
    Kaneko, Masahito
    Kusano, Mikiko
    Yamada, Shunsuke
    Takeshita, Shigeru
    Miyawaki, Shuichi
    Naoe, Tomoki
    CANCER SCIENCE, 2018, 109 (10): : 3235 - 3244
  • [47] Local Mesenchymal Stem Cells injection in Crohn's disease strictures: a phase I-II, open-label clinical study
    Vieujean, S.
    Loly, J. P.
    Boutaffala, L.
    Pariente, B.
    Reenaers, C.
    Briquet, A.
    Lechanteur, C.
    Beguin, Y.
    Louis, E.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S323 - S324
  • [48] An Open-Label, Multicenter Observational Study for Patients with Alzheimer's Disease Treated with Memantine in the Clinical Practice
    Stamouli, S. S.
    Tzanakaki, M.
    Giatas, S.
    Georgiadis, G.
    Papalexi, E.
    Parashos, I. A.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 10 - 19
  • [49] A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
    Dawson, Mark A.
    Borthakur, Gautam
    Huntly, Brian J. P.
    Karadimitris, Anastasios
    Alegre, Adrian
    Chaidos, Aristeidis
    Vogl, Dan T.
    Pollyea, Daniel A.
    Davies, Faith E.
    Morgan, Gareth J.
    Glass, Jacob L.
    Kamdar, Manali
    Mateos, Maria -Victoria
    Tovar, Natalia
    Yeh, Paul
    Delgado, Regina Garcia
    Basheer, Faisal
    Marando, Ludovica
    Gallipoli, Paolo
    Wyce, Anastasia
    Krishnatry, Anu Shilpa
    Barbash, Olena
    Bakirtzi, Evi
    Ferron-Brady, Geraldine
    Karpinich, Natalie O.
    McCabe, Michael T.
    Foley, Shawn W.
    Horner, Thierry
    Dhar, Arindam
    Kremer, Brandon E.
    Dickinson, Michael
    CLINICAL CANCER RESEARCH, 2023, 29 (04) : 711 - 722
  • [50] Cannabidiol in treatment of refractory epileptic spasms: An open-label study
    Herlopian, Aline
    Hess, Evan J.
    Barnett, James
    Geffrey, Alexandra L.
    Pollack, Sarah F.
    Skirvin, Lauren
    Bruno, Patricia
    Sourbron, Jo
    Thiele, Elizabeth A.
    EPILEPSY & BEHAVIOR, 2020, 106
12345